Truveta collaboration with Harvard University researchers published in JAMA Network Open
11 mai 2023 09h42 HE
|
Truveta
BELLEVUE, Wash., May 11, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced a new research letter published in Jama Network Open using de-identified patient data from Truveta Studio. Published in...
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
12 avr. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., April 12, 2023 (GLOBE NEWSWIRE) -- Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for transforming electronic health record (EHR)...
Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials
22 mars 2023 08h45 HE
|
Truveta
BELLEVUE and SEATTLE, Wash., March 22, 2023 (GLOBE NEWSWIRE) -- Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
01 mars 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., March 01, 2023 (GLOBE NEWSWIRE) -- Truveta announced the expansion of its de-identified data to include 28 additional social drivers of health (SDOH) attributes – such as education,...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
23 févr. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
23 févr. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
New Research: Preeclampsia-related heart failure disproportionately impacts Black mothers
08 févr. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new maternal heart health and health equity research from Truveta Studio that explored nearly 500,000 female patient...
Truveta expands with three new US health system members
24 janv. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Three healthcare providers — HealthPartners, HonorHealth, and TriHealth — have joined Truveta, the company with a vision of saving lives with...
Truveta Research shares new insights on RSV hospitalization trends
19 janv. 2023 12h00 HE
|
Truveta
BELLEVUE, Wash., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Today, Truveta released new research comparing the rates of RSV to previous years. With the rising rates of respiratory syncytial virus (RSV)...
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
19 janv. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 health equity research published in Frontiers in Public Health using de-identified patient data from Truveta...